Arformoterol tartrate
Biological Activity
Long-acting β2 adrenergic agonist (LABA). Bronchodilator.
Technical Data
| M. Wt | 494.49 |
| Formula | C19H24N2O4.C4H6O6 |
| Storage | Store at +4°C |
| Purity | ≥98% (HPLC) |
| CAS Number | 200815-49-2 |
| PubChem ID | 9827062 |
| InChI Key | FCSXYHUNDAXDRH-OKMNHOJOSA-N |
| Smiles | O[C@@H](C(O)=O)[C@H](C(O)=O)O.COC1=CC=C(C=C1)C[C@H](NC[C@@H](C2=CC(NC=O)=C(C=C2)O)O)C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Solubility Data
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 49.45 | 100 | |
| water | 9.89 | 20 |
Preparing Stock Solutions
The following data is based on the product molecular weight 494.49. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 2.02 mL | 10.11 mL | 20.22 mL |
| 5 mM | 0.4 mL | 2.02 mL | 4.04 mL |
| 10 mM | 0.2 mL | 1.01 mL | 2.02 mL |
| 50 mM | 0.04 mL | 0.2 mL | 0.4 mL |
Molarity Calculator
Reconstitution Calculator
Dilution Calculator
Product Datasheets
References
References are publications that support the products' biological activity.
Op't Holt et al (2007) Inhaled beta agonists. Respir.Care 52 820 PMID: 17594727
If you know of a relevant reference for Arformoterol tartrate, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Arformoterol tartrate, supplier, B2, Beta2, β2, adrenergic, agonists, agonism, long-acting, LABA, Bronchodilator, Adrenergic, Beta-2, Receptors, Adrenergic, Beta-2, Receptors, Tocris Bioscience
Citations for Arformoterol tartrate
Citations are publications that use Tocris products.
Currently there are no citations for Arformoterol tartrate. Do you know of a great paper that uses Arformoterol tartrate from Tocris? If so please let us know.
Reviews for Arformoterol tartrate
There are currently no reviews for this product. Be the first to review Arformoterol tartrate and earn rewards!
Have you used Arformoterol tartrate?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and Europe
Submit a ReviewLiterature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Cardiovascular Research Product Guide
A collection of over 250 products for cardiovascular research, the guide includes research tools for the study of:
- Hypertension
- Thrombosis and Hemostasis
- Atherosclerosis
- Myocardial Infarction
- Ischemia/Reperfusion Injury
- Arrhythmias
- Heart Failure
GPCR Product Listing
A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:
- Rhodopsin-like Receptors
- Secretin-like Receptors
- Glutamate Receptors
- Frizzled Receptors
- GPCR Signaling
Asthma Poster
Asthma is one of the most common chronic diseases in the world, affecting over 300 million people. This poster highlights key pathways and new therapies used to treat the condition, including those currently in clinical development.
Cardiovascular Poster
Cardiovascular disease remains one of the major causes of morbidity and mortality in the Western world and therefore this therapeutic area continues to be of great interest to researchers. This poster highlights the key GPCRs regulating vascular reactivity.
Depression Poster
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.
